Pharmafile Logo

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell, 2020). A 2023 study calculated that these financial losses can reach approximately $500,000 in lost drug sales and $40,000 in direct clinical trial costs per day of delay (appliedclinicaltrialsonline.com), so the sites chosen to participate in the trial and the support provided to them during patient recruitment can be one of the major deciding factors between an on-time trial and a delayed, over-budget trial.

- PMLiVE

🔍 Is Your Influenza Clinical Trial Ready for the Upcoming Flu Season? 🩺
The clock is ticking—flu season is just around the corner! With 86% of clinical trials failing to meet recruitment goals, it’s crucial that your sites are fully prepared to recruit patients effectively.

Our latest blog explores key strategies to enhance site motivation, streamline recruitment processes, and overcome common challenges in patient recruitment. Don’t let delays cost you—read Part #2 of our series to ensure your trial is on track for success this flu season.

🚀 Read the full blog and boost your recruitment strategy today! 👉 https://bit.ly/4cFG7ql

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Kate Shaw reflects on Innovative Trials’ first US office openings

On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening

Innovative Trials on the latest ABPI report

Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report

Innovative Trials featuring in a Clinical Trials Arena article

Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.

Overcoming Patient Recruitment Challenges in Rare Disease Trials

Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

FREE Live Webinar – Overcoming Patient Recruitment Challenges in Rare Disease Trials

Innovative Trials and Pfizer invite you to attend the live webinar

Innovative Trials opens first US office

We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

Accelerating patient recruitment post-COVID-19

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Innovative Trials opens first US office

The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina

Windrush Day

Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation

Celebrating World Blood Donor Day

Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.